by John Conrad | Jul 24, 2024 | NewsBrief
In a significant development for Illinois’ healthcare technology sector, Endotronix has been acquired by Edwards Lifesciences, a global leader in patient-focused innovations for structural heart disease and critical care monitoring. This acquisition marks a...
by John Conrad | Jul 24, 2024 | NewsBrief
The University of Chicago’s Polsky Center for Entrepreneurship and Innovation has forged a strategic partnership with Orange Grove Bio (OGB), an integrated biopharmaceutical company, in a move set to accelerate biotech innovation and commercialization. This...
by John Conrad | Jul 24, 2024 | NewsBrief
Valinor Pharma, LLC (“Valinor”) has announced its acquisition by Grünenthal in an all-stock deal valued at approximately $250 million in upfront cash consideration. This acquisition marks a significant milestone for Valinor, which has owned the global...
by John Conrad | Jul 22, 2024 | iBIO News
The biotech sector has experienced a remarkable turnaround in 2024, with the SPDR S&P Biotech ETF (XBI) climbing 22% from its April low and posting an 11% year-to-date gain. This recovery reflects renewed optimism in an industry that has overcome significant...
by John Conrad | Jul 19, 2024 | NewsBrief
In a strategic move to expand its specialty biopharmaceuticals portfolio, Meitheal Pharmaceuticals has acquired the North American rights to CONTEPO™ (fosfomycin for injection) from Nabriva Therapeutics. The announcement, made on July 18, 2024, marks a significant...
